Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medipharm Labs Corp (OP:MEDIF)

0.0595 +0.0022 (+3.84%)
Streaming Delayed Price Updated: 11:24 AM EDT, Jun 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medipharm Labs Corp

< Previous 1 2 3 4 5 Next >
MediPharm Labs Begins Restructuring Following Acquisition Of VIVO, Reduces Non-Direct Labor Workforce By ~30%
MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) provided an update on progress made on the integration of VIVO Cannabis Inc.'s (OTCQB: VVCIF) operations follow 
Via Benzinga
The Canadian Cannabis Report - Monday, April 10
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 17 stocks. 
Via Talk Markets
MediPharm Labs FY22 Revenue Grows Slightly To $16.3M
MediPharm Labs Corp. (TSX:LABS) (OTCQX: MEDIF) (FSE:MLZ) FY 2022 revenue was CA$22.1 million ($16.3 million), an increase of 1.8% compared to CA$21.7 million in FY 2021. 
Via Benzinga
MediPharm Labs Shareholders Approve Merger With VIVO Cannabis
MediPharm Labs Corp. 
Via Benzinga
Historic Ruling To Legalize Cannabis Cultivation In Brazil: These Weed Companies Will Likely Benefit
Following years of stalling on the issue of legal cultivation of cannabis for medicinal and industrial purposes, a Brazilian appeals court is set to rule on allowing businesses and farmers to... 
Via Benzinga
MediPharm Labs Awarded Payment Of $9.8M By Ontario Court Of Justice
MediPharm Labs Corp. 
Via Benzinga
MediPharm Labs To Acquire VIVO Cannabis
MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE: MLZ) and VIVO Cannabis Inc. 
Via Benzinga
MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.
Two global leaders in the medical wellness cannabis industry expected to combine complementary strengths of diversified revenue in multiple markets... 
Via Newsfile
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, Dec. 19
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 21 stocks. 
Via Talk Markets
The Canadian Cannabis Report - Monday, Nov.28
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 21 stocks. 
Via Talk Markets
The Canadian Cannabis Report - Monday, Nov. 21
The past, present and future of the Canadian cannabis sector, based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
MediPharm Touts Strong Q3 Revenue Growth, Continues To Expand Internationally
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced on Monday its financial results for the three months ended Sept. 30, 2022. 
Via Benzinga
The Canadian Cannabis Report - Monday, Nov. 14
The past, present, and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
The Canadian Cannabis Report - Monday, Aug. 29
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
The Canadian Cannabis Report - Monday, Aug. 15
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
MediPharm Labs Q2 Revenue Declines 14% YoY, Here Are The Details
MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) Q2 2022 revenue declined 14%, to CA$4.36 million ($3,37 million), compared to revenue of CA$5.07 million in Q2 2021. 
Via Benzinga
The Canadian Cannabis Report - Monday, Aug. 1
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
The Canadian Cannabis Report - Monday, July 25
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
MediPharm Labs Enters Into $4.68M Purchase Agreement For The Sale Of Australian Facility
MediPharm Labs Corp. 
Via Benzinga
The Canadian Cannabis Report - Monday, June 20
The past, present and future of the Canadian cannabis sector, based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
BREAKING: Brazil Supreme Court Authorizes Citizens To Grow Medicinal Cannabis
What Happened? 
Via Benzinga
The Canadian Cannabis Report- Monday, May 23
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
The Canadian Cannabis Report - Monday, May 16
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
MediPharm Labs Q1 Revenue Slightly Drops, Here Are The Details
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) revenue decreased 11.24% to $4.88 million in Q1 2022 compared to $5.5 million in Q1 2021. 
Via Benzinga
The Canadian Cannabis Report - Monday, May 9
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
Cannabis Movers & Shakers: SuperNet, MediPharm, Le-Vel, Jupiter Wellness, Leafly, Acreage
SuperNet Names John Pfisterer As CFO SuperNet, a payment network that enables credit card payments for cannabis merchants and consumers, has tapped John Pfisterer to oversee its financial department. 
Via Benzinga
MediPharm Labs Launches CBG And Water-Soluble CBN:THC Products
MediPharm Labs Corp. (OTCQX: MEDIF) (TSX: LABS) (FSE: MLZ) launched CBG and water-soluble products. As of today, these new products will be available in Ontario in both retail stores and on the OCS... 
Via Benzinga
MediPharm Labs Reports Fourth Quarter And Full Year 2021 Results, International Sales Double To $9.5M
MediPharm Labs Corp. (OTC: MEDIF) a pharmaceutical company specializing in precision-based cannabinoids, announced on Thursday its financial results for the Fourth Quarter and Full-Year that ended on... 
Via Benzinga
MediPharm Labs Acquires Shelter Cannabis Brands' IP To Expand Portfolio With Flower And Pre-Rolls
MediPharm Labs Corp. (OTCQX:MEDIF) (TSXV: 
Via Benzinga
MediPharm Labs Debuts On US Pharmaceutical Market With Submission Of FDA DMF
CBD-based pharmaceutical company MediPharm Labs Corp. (TSX:LABS 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.